NovaSight is a company that specializes in pediatric vision care, leveraging eye-tracking technology and data analytics to create innovative solutions for vision health monitoring, myopia prevention, and the treatment of conditions like amblyopia, commonly known as lazy eye. They offer products such as CureSight™, EyeSwift®PRO, and TrackSight™, which aim to provide engaging, child-friendly activities for vision assessment and treatment, without the need for uncomfortable patching. Their technology includes optical IR sensors for eye-tracking, proprietary ActiveSight™ Glasses for remote-controlled eye occlusion, and the use of AI and big data for insights into eye patterns and vision population norms. These solutions are designed to be more accurate and repeatable than traditional methods, offering benefits to both patients and healthcare providers in terms of engagement, comfort, and efficiency. NovaSight's products like CureSight™ have received regulatory clearances such as CE marking and FDA 510(K), while EyeSwift®PRO is currently an investigational device. TrackSight™ is not yet approved for sales. The company is based in Israel and is dedicated to enabling children worldwide to live their dreams by revolutionizing pediatric vision care.